Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$280,143,283
-$19,854,544 QoQ
Shares Held
2,217,376
+3.0% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#69
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $598,181,374 across 8 Drug Manufacturers - General names. GILD ranks #1 (46.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
2,217,376 | $280,143,283 | |
| 2 | NVO |
Novo Nordisk A S
|
3,032,421 | $145,374,262 | |
| 3 | NVS |
Novartis AG
|
788,033 | $123,500,531 | |
| 4 | LLY |
ELI LILLY & Co
|
26,091 | $31,294,330 | |
| 5 | BIIB |
Biogen Inc.
|
77,744 | $16,797,368 | |
| 6 | AMRN |
Amarin Corp Plc\Uk
|
48,369 | $771,001 | |
| 7 | SCLX |
Scilex Holding Co
|
33,064 | $257,899 | |
| 8 | NSRX |
Nasus Pharma Ltd
|
12,200 | $42,700 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $280,143,283 | 2,217,376 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $299,997,827 | 2,152,528 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $342,288,474 | 2,788,728 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $606,364,584 | 5,462,744 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $628,232,881 | 5,666,392 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $610,800,573 | 5,451,143 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $492,308,360 | 5,329,743 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $351,165,852 | 4,188,524 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $347,001,798 | 5,057,598 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $316,267,862 | 4,317,650 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $451,699,608 | 5,575,850 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $482,867,196 | 6,443,384 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $599,713,731 | 7,781,416 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $878,172,401 | 10,584,216 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $790,040,462 | 9,202,568 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $618,292,219 | 10,022,568 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $828,848,364 | 13,409,616 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $921,006,296 | 15,492,116 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $659,449,030 | 9,082,069 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $384,241,706 | 5,500,955 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $347,560,865 | 5,047,355 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $424,037,623 | 6,561,003 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $371,393,634 | 6,374,762 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $483,522,234 | 7,651,879 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $684,861,944 | 8,901,247 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $936,833,184 | 12,531,209 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||